nodes	percent_of_prediction	percent_of_DWPC	metapath
Raloxifene—AOX1—Mercaptopurine—Crohn's disease	0.829	0.963	CbGbCtD
Raloxifene—CYP3A4—Prednisone—Crohn's disease	0.0319	0.037	CbGbCtD
Raloxifene—Gastrointestinal symptom NOS—Mesalazine—Crohn's disease	0.00319	0.0283	CcSEcCtD
Raloxifene—Cholelithiasis—Mesalazine—Crohn's disease	0.00301	0.0267	CcSEcCtD
Raloxifene—Neoplasm malignant—Azathioprine—Crohn's disease	0.00241	0.0214	CcSEcCtD
Raloxifene—Breast disorder—Mercaptopurine—Crohn's disease	0.00227	0.0201	CcSEcCtD
Raloxifene—Tenderness—Mesalazine—Crohn's disease	0.00215	0.0191	CcSEcCtD
Raloxifene—Breast pain—Mesalazine—Crohn's disease	0.00215	0.0191	CcSEcCtD
Raloxifene—Vasodilation procedure—Mesalazine—Crohn's disease	0.00213	0.0189	CcSEcCtD
Raloxifene—Vasodilation—Mesalazine—Crohn's disease	0.00213	0.0189	CcSEcCtD
Raloxifene—Cough increased—Mesalazine—Crohn's disease	0.00205	0.0182	CcSEcCtD
Raloxifene—AOX1—gall bladder—Crohn's disease	0.00203	0.113	CbGeAlD
Raloxifene—Embolism venous—Prednisone—Crohn's disease	0.00196	0.0174	CcSEcCtD
Raloxifene—Vaginal inflammation—Mesalazine—Crohn's disease	0.00187	0.0166	CcSEcCtD
Raloxifene—Cystitis noninfective—Mesalazine—Crohn's disease	0.00183	0.0162	CcSEcCtD
Raloxifene—Cystitis—Mesalazine—Crohn's disease	0.00181	0.0161	CcSEcCtD
Raloxifene—Vaginal infection—Mesalazine—Crohn's disease	0.00177	0.0157	CcSEcCtD
Raloxifene—Cramps of lower extremities—Mesalazine—Crohn's disease	0.00172	0.0153	CcSEcCtD
Raloxifene—Bladder pain—Mesalazine—Crohn's disease	0.00169	0.015	CcSEcCtD
Raloxifene—Embolism—Prednisone—Crohn's disease	0.00154	0.0137	CcSEcCtD
Raloxifene—Gastroenteritis—Mesalazine—Crohn's disease	0.00153	0.0136	CcSEcCtD
Raloxifene—Arthritis—Mesalazine—Crohn's disease	0.0014	0.0124	CcSEcCtD
Raloxifene—Migraine—Mesalazine—Crohn's disease	0.00134	0.0119	CcSEcCtD
Raloxifene—Arthralgia—Mercaptopurine—Crohn's disease	0.00129	0.0114	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.00128	0.0113	CcSEcCtD
Raloxifene—Breast disorder—Mesalazine—Crohn's disease	0.00123	0.0109	CcSEcCtD
Raloxifene—Aspartate aminotransferase increased—Mesalazine—Crohn's disease	0.00123	0.0109	CcSEcCtD
Raloxifene—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.00121	0.0107	CcSEcCtD
Raloxifene—Skin disorder—Mercaptopurine—Crohn's disease	0.0012	0.0106	CcSEcCtD
Raloxifene—Influenza—Mesalazine—Crohn's disease	0.00118	0.0104	CcSEcCtD
Raloxifene—Pneumonia—Azathioprine—Crohn's disease	0.00116	0.0103	CcSEcCtD
Raloxifene—Bronchitis—Mesalazine—Crohn's disease	0.00113	0.01	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.00112	0.00996	CcSEcCtD
Raloxifene—ESR2—epithelium—Crohn's disease	0.00109	0.0606	CbGeAlD
Raloxifene—Weight increased—Mesalazine—Crohn's disease	0.00107	0.0095	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00106	0.00944	CcSEcCtD
Raloxifene—Pneumonia—Mesalazine—Crohn's disease	0.00105	0.00936	CcSEcCtD
Raloxifene—ESR2—smooth muscle tissue—Crohn's disease	0.00105	0.0584	CbGeAlD
Raloxifene—Depression—Mesalazine—Crohn's disease	0.00105	0.00928	CcSEcCtD
Raloxifene—Conjunctivitis—Mesalazine—Crohn's disease	0.00102	0.00904	CcSEcCtD
Raloxifene—Urinary tract infection—Mesalazine—Crohn's disease	0.00102	0.00904	CcSEcCtD
Raloxifene—Sweating—Mesalazine—Crohn's disease	0.00101	0.00892	CcSEcCtD
Raloxifene—Sinusitis—Mesalazine—Crohn's disease	0.000984	0.00873	CcSEcCtD
Raloxifene—Body temperature increased—Mercaptopurine—Crohn's disease	0.000974	0.00864	CcSEcCtD
Raloxifene—Rhinitis—Mesalazine—Crohn's disease	0.000944	0.00837	CcSEcCtD
Raloxifene—Pharyngitis—Mesalazine—Crohn's disease	0.000934	0.00829	CcSEcCtD
Raloxifene—Urinary tract disorder—Mesalazine—Crohn's disease	0.000929	0.00825	CcSEcCtD
Raloxifene—Oedema peripheral—Mesalazine—Crohn's disease	0.000927	0.00823	CcSEcCtD
Raloxifene—Connective tissue disorder—Mesalazine—Crohn's disease	0.000925	0.00821	CcSEcCtD
Raloxifene—Urethral disorder—Mesalazine—Crohn's disease	0.000923	0.00819	CcSEcCtD
Raloxifene—AOX1—mammalian vulva—Crohn's disease	0.000911	0.0506	CbGeAlD
Raloxifene—Cardiac disorder—Mesalazine—Crohn's disease	0.000873	0.00775	CcSEcCtD
Raloxifene—Angiopathy—Mesalazine—Crohn's disease	0.000854	0.00758	CcSEcCtD
Raloxifene—Diarrhoea—Mercaptopurine—Crohn's disease	0.000843	0.00748	CcSEcCtD
Raloxifene—ESR2—lymphoid tissue—Crohn's disease	0.000841	0.0466	CbGeAlD
Raloxifene—ESR2—digestive system—Crohn's disease	0.00083	0.0461	CbGeAlD
Raloxifene—Diabetes mellitus—Prednisone—Crohn's disease	0.000828	0.00734	CcSEcCtD
Raloxifene—SIGMAR1—smooth muscle tissue—Crohn's disease	0.000815	0.0452	CbGeAlD
Raloxifene—HTR2B—smooth muscle tissue—Crohn's disease	0.000813	0.0451	CbGeAlD
Raloxifene—Flatulence—Mesalazine—Crohn's disease	0.000807	0.00716	CcSEcCtD
Raloxifene—HTR2B—skin of body—Crohn's disease	0.000802	0.0445	CbGeAlD
Raloxifene—AOX1—digestive system—Crohn's disease	0.000799	0.0443	CbGeAlD
Raloxifene—Muscle spasms—Mesalazine—Crohn's disease	0.000788	0.00699	CcSEcCtD
Raloxifene—Vomiting—Mercaptopurine—Crohn's disease	0.000783	0.00695	CcSEcCtD
Raloxifene—Rash—Mercaptopurine—Crohn's disease	0.000777	0.00689	CcSEcCtD
Raloxifene—Dermatitis—Mercaptopurine—Crohn's disease	0.000776	0.00689	CcSEcCtD
Raloxifene—Myalgia—Azathioprine—Crohn's disease	0.000766	0.00679	CcSEcCtD
Raloxifene—Arthralgia—Azathioprine—Crohn's disease	0.000766	0.00679	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.00076	0.00675	CcSEcCtD
Raloxifene—ESR1—epithelium—Crohn's disease	0.000747	0.0415	CbGeAlD
Raloxifene—Vertigo—Mesalazine—Crohn's disease	0.000736	0.00653	CcSEcCtD
Raloxifene—Syncope—Mesalazine—Crohn's disease	0.000735	0.00652	CcSEcCtD
Raloxifene—SIGMAR1—mammalian vulva—Crohn's disease	0.000733	0.0407	CbGeAlD
Raloxifene—Nausea—Mercaptopurine—Crohn's disease	0.000732	0.00649	CcSEcCtD
Raloxifene—Infection—Azathioprine—Crohn's disease	0.000729	0.00647	CcSEcCtD
Raloxifene—ESR1—smooth muscle tissue—Crohn's disease	0.00072	0.04	CbGeAlD
Raloxifene—Loss of consciousness—Mesalazine—Crohn's disease	0.00072	0.00639	CcSEcCtD
Raloxifene—Thrombocytopenia—Azathioprine—Crohn's disease	0.000719	0.00638	CcSEcCtD
Raloxifene—Cough—Mesalazine—Crohn's disease	0.000715	0.00634	CcSEcCtD
Raloxifene—Skin disorder—Azathioprine—Crohn's disease	0.000713	0.00633	CcSEcCtD
Raloxifene—Myalgia—Mesalazine—Crohn's disease	0.000697	0.00619	CcSEcCtD
Raloxifene—Arthralgia—Mesalazine—Crohn's disease	0.000697	0.00619	CcSEcCtD
Raloxifene—Chest pain—Mesalazine—Crohn's disease	0.000697	0.00619	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.000693	0.00615	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000669	0.00593	CcSEcCtD
Raloxifene—Infection—Mesalazine—Crohn's disease	0.000664	0.00589	CcSEcCtD
Raloxifene—Shock—Mesalazine—Crohn's disease	0.000658	0.00584	CcSEcCtD
Raloxifene—Nervous system disorder—Mesalazine—Crohn's disease	0.000656	0.00582	CcSEcCtD
Raloxifene—Thrombocytopenia—Mesalazine—Crohn's disease	0.000655	0.00581	CcSEcCtD
Raloxifene—Skin disorder—Mesalazine—Crohn's disease	0.000649	0.00576	CcSEcCtD
Raloxifene—Hyperhidrosis—Mesalazine—Crohn's disease	0.000646	0.00574	CcSEcCtD
Raloxifene—HTR2B—digestive system—Crohn's disease	0.000642	0.0356	CbGeAlD
Raloxifene—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.000634	0.00562	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000609	0.00541	CcSEcCtD
Raloxifene—Insomnia—Mesalazine—Crohn's disease	0.000605	0.00537	CcSEcCtD
Raloxifene—Gastrointestinal pain—Azathioprine—Crohn's disease	0.0006	0.00533	CcSEcCtD
Raloxifene—Dyspepsia—Mesalazine—Crohn's disease	0.000589	0.00522	CcSEcCtD
Raloxifene—Body temperature increased—Azathioprine—Crohn's disease	0.00058	0.00515	CcSEcCtD
Raloxifene—Abdominal pain—Azathioprine—Crohn's disease	0.00058	0.00515	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.000577	0.00512	CcSEcCtD
Raloxifene—ESR1—lymphoid tissue—Crohn's disease	0.000576	0.0319	CbGeAlD
Raloxifene—Pain—Mesalazine—Crohn's disease	0.000572	0.00507	CcSEcCtD
Raloxifene—ESR1—digestive system—Crohn's disease	0.000569	0.0316	CbGeAlD
Raloxifene—Weight increased—Prednisone—Crohn's disease	0.000566	0.00502	CcSEcCtD
Raloxifene—Depression—Prednisone—Crohn's disease	0.000553	0.00491	CcSEcCtD
Raloxifene—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000547	0.00485	CcSEcCtD
Raloxifene—Abdominal pain—Mesalazine—Crohn's disease	0.000529	0.00469	CcSEcCtD
Raloxifene—Body temperature increased—Mesalazine—Crohn's disease	0.000529	0.00469	CcSEcCtD
Raloxifene—CYP2B6—skin of body—Crohn's disease	0.000525	0.0291	CbGeAlD
Raloxifene—Diarrhoea—Azathioprine—Crohn's disease	0.000502	0.00446	CcSEcCtD
Raloxifene—Connective tissue disorder—Prednisone—Crohn's disease	0.000489	0.00434	CcSEcCtD
Raloxifene—Dizziness—Azathioprine—Crohn's disease	0.000485	0.00431	CcSEcCtD
Raloxifene—ESR2—lymph node—Crohn's disease	0.000474	0.0263	CbGeAlD
Raloxifene—Vomiting—Azathioprine—Crohn's disease	0.000467	0.00414	CcSEcCtD
Raloxifene—Rash—Azathioprine—Crohn's disease	0.000463	0.00411	CcSEcCtD
Raloxifene—Dermatitis—Azathioprine—Crohn's disease	0.000462	0.0041	CcSEcCtD
Raloxifene—Flushing—Prednisone—Crohn's disease	0.000462	0.0041	CcSEcCtD
Raloxifene—Headache—Azathioprine—Crohn's disease	0.00046	0.00408	CcSEcCtD
Raloxifene—Diarrhoea—Mesalazine—Crohn's disease	0.000457	0.00406	CcSEcCtD
Raloxifene—AOX1—lymph node—Crohn's disease	0.000457	0.0253	CbGeAlD
Raloxifene—Angiopathy—Prednisone—Crohn's disease	0.000452	0.00401	CcSEcCtD
Raloxifene—Dizziness—Mesalazine—Crohn's disease	0.000442	0.00392	CcSEcCtD
Raloxifene—Nausea—Azathioprine—Crohn's disease	0.000436	0.00387	CcSEcCtD
Raloxifene—CYP2B6—lymphoid tissue—Crohn's disease	0.000425	0.0236	CbGeAlD
Raloxifene—Vomiting—Mesalazine—Crohn's disease	0.000425	0.00377	CcSEcCtD
Raloxifene—Rash—Mesalazine—Crohn's disease	0.000422	0.00374	CcSEcCtD
Raloxifene—Dermatitis—Mesalazine—Crohn's disease	0.000421	0.00374	CcSEcCtD
Raloxifene—CYP2B6—digestive system—Crohn's disease	0.00042	0.0233	CbGeAlD
Raloxifene—Headache—Mesalazine—Crohn's disease	0.000419	0.00372	CcSEcCtD
Raloxifene—Nausea—Mesalazine—Crohn's disease	0.000397	0.00352	CcSEcCtD
Raloxifene—Vertigo—Prednisone—Crohn's disease	0.000389	0.00346	CcSEcCtD
Raloxifene—Syncope—Prednisone—Crohn's disease	0.000389	0.00345	CcSEcCtD
Raloxifene—Loss of consciousness—Prednisone—Crohn's disease	0.000381	0.00338	CcSEcCtD
Raloxifene—CYP19A1—lymph node—Crohn's disease	0.000374	0.0207	CbGeAlD
Raloxifene—Arthralgia—Prednisone—Crohn's disease	0.000369	0.00327	CcSEcCtD
Raloxifene—Myalgia—Prednisone—Crohn's disease	0.000369	0.00327	CcSEcCtD
Raloxifene—SIGMAR1—lymph node—Crohn's disease	0.000367	0.0204	CbGeAlD
Raloxifene—HTR2B—lymph node—Crohn's disease	0.000367	0.0203	CbGeAlD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.000366	0.00325	CcSEcCtD
Raloxifene—Infection—Prednisone—Crohn's disease	0.000351	0.00312	CcSEcCtD
Raloxifene—Shock—Prednisone—Crohn's disease	0.000348	0.00309	CcSEcCtD
Raloxifene—Nervous system disorder—Prednisone—Crohn's disease	0.000347	0.00308	CcSEcCtD
Raloxifene—Skin disorder—Prednisone—Crohn's disease	0.000344	0.00305	CcSEcCtD
Raloxifene—Hyperhidrosis—Prednisone—Crohn's disease	0.000342	0.00303	CcSEcCtD
Raloxifene—ESR1—lymph node—Crohn's disease	0.000325	0.018	CbGeAlD
Raloxifene—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000322	0.00286	CcSEcCtD
Raloxifene—Insomnia—Prednisone—Crohn's disease	0.00032	0.00284	CcSEcCtD
Raloxifene—CYP3A4—digestive system—Crohn's disease	0.000317	0.0176	CbGeAlD
Raloxifene—Dyspepsia—Prednisone—Crohn's disease	0.000311	0.00276	CcSEcCtD
Raloxifene—Gastrointestinal pain—Prednisone—Crohn's disease	0.000289	0.00257	CcSEcCtD
Raloxifene—Abdominal pain—Prednisone—Crohn's disease	0.00028	0.00248	CcSEcCtD
Raloxifene—Body temperature increased—Prednisone—Crohn's disease	0.00028	0.00248	CcSEcCtD
Raloxifene—Diarrhoea—Prednisone—Crohn's disease	0.000242	0.00215	CcSEcCtD
Raloxifene—Dizziness—Prednisone—Crohn's disease	0.000234	0.00208	CcSEcCtD
Raloxifene—Vomiting—Prednisone—Crohn's disease	0.000225	0.002	CcSEcCtD
Raloxifene—Rash—Prednisone—Crohn's disease	0.000223	0.00198	CcSEcCtD
Raloxifene—Dermatitis—Prednisone—Crohn's disease	0.000223	0.00198	CcSEcCtD
Raloxifene—Headache—Prednisone—Crohn's disease	0.000222	0.00197	CcSEcCtD
Raloxifene—Nausea—Prednisone—Crohn's disease	0.00021	0.00186	CcSEcCtD
Raloxifene—HTR6—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	4.24e-05	0.00514	CbGpPWpGaD
Raloxifene—HTR6—GPCR ligand binding—CCR9—Crohn's disease	4.18e-05	0.00506	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—TAB1—Crohn's disease	3.92e-05	0.00476	CbGpPWpGaD
Raloxifene—EBP—Metabolism—FADS1—Crohn's disease	3.92e-05	0.00476	CbGpPWpGaD
Raloxifene—CYP2B6—Metapathway biotransformation—GPX4—Crohn's disease	3.9e-05	0.00473	CbGpPWpGaD
Raloxifene—HTR6—GPCR ligand binding—GPR65—Crohn's disease	3.88e-05	0.00471	CbGpPWpGaD
Raloxifene—HTR2B—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	3.87e-05	0.00469	CbGpPWpGaD
Raloxifene—HTR2B—GPCR ligand binding—CCR9—Crohn's disease	3.81e-05	0.00462	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	3.81e-05	0.00462	CbGpPWpGaD
Raloxifene—HTR6—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	3.73e-05	0.00453	CbGpPWpGaD
Raloxifene—EBP—Metabolism—GPX4—Crohn's disease	3.67e-05	0.00445	CbGpPWpGaD
Raloxifene—ESR1—ATF-2 transcription factor network—IFNG—Crohn's disease	3.64e-05	0.00441	CbGpPWpGaD
Raloxifene—HTR6—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	3.63e-05	0.00441	CbGpPWpGaD
Raloxifene—HTR2B—G alpha (q) signalling events—RASGRP1—Crohn's disease	3.63e-05	0.0044	CbGpPWpGaD
Raloxifene—EBP—Metabolism—GCKR—Crohn's disease	3.55e-05	0.0043	CbGpPWpGaD
Raloxifene—HTR2B—GPCR ligand binding—GPR65—Crohn's disease	3.54e-05	0.0043	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—TAB1—Crohn's disease	3.51e-05	0.00426	CbGpPWpGaD
Raloxifene—AOX1—Disease—RSPO3—Crohn's disease	3.43e-05	0.00415	CbGpPWpGaD
Raloxifene—HTR2B—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	3.41e-05	0.00413	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—MLN—Crohn's disease	3.41e-05	0.00413	CbGpPWpGaD
Raloxifene—ESR1—ATF-2 transcription factor network—CXCL8—Crohn's disease	3.38e-05	0.0041	CbGpPWpGaD
Raloxifene—HTR2B—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	3.32e-05	0.00402	CbGpPWpGaD
Raloxifene—CYP2C8—Metapathway biotransformation—GPX4—Crohn's disease	3.3e-05	0.004	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—PLA2G4F—Crohn's disease	3.28e-05	0.00398	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—ACKR2—Crohn's disease	3.26e-05	0.00396	CbGpPWpGaD
Raloxifene—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—Crohn's disease	3.25e-05	0.00394	CbGpPWpGaD
Raloxifene—ESR1—Regulation of Telomerase—IFNG—Crohn's disease	3.25e-05	0.00394	CbGpPWpGaD
Raloxifene—AOX1—Disease—SEL1L—Crohn's disease	3.25e-05	0.00394	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	3.24e-05	0.00393	CbGpPWpGaD
Raloxifene—ESR2—Generic Transcription Pathway—UBE2D1—Crohn's disease	3.2e-05	0.00389	CbGpPWpGaD
Raloxifene—HTR6—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	3.2e-05	0.00388	CbGpPWpGaD
Raloxifene—ESR1—AP-1 transcription factor network—IFNG—Crohn's disease	3.17e-05	0.00385	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—MLN—Crohn's disease	3.11e-05	0.00377	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—MLN—Crohn's disease	3.09e-05	0.00375	CbGpPWpGaD
Raloxifene—ESR2—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	3.08e-05	0.00374	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	3.08e-05	0.00373	CbGpPWpGaD
Raloxifene—ESR2—Gene Expression—ZFP36L1—Crohn's disease	3.06e-05	0.00371	CbGpPWpGaD
Raloxifene—ESR1—Leptin signaling pathway—JAK2—Crohn's disease	3.06e-05	0.00371	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—ACKR2—Crohn's disease	2.98e-05	0.00361	CbGpPWpGaD
Raloxifene—ESR2—SIDS Susceptibility Pathways—IL1B—Crohn's disease	2.96e-05	0.00358	CbGpPWpGaD
Raloxifene—ESR1—AP-1 transcription factor network—CXCL8—Crohn's disease	2.95e-05	0.00358	CbGpPWpGaD
Raloxifene—HTR2B—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	2.92e-05	0.00354	CbGpPWpGaD
Raloxifene—AOX1—Disease—LTF—Crohn's disease	2.91e-05	0.00353	CbGpPWpGaD
Raloxifene—ESR1—Aryl Hydrocarbon Receptor—TNF—Crohn's disease	2.87e-05	0.00348	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—MLN—Crohn's disease	2.82e-05	0.00342	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—MTMR3—Crohn's disease	2.79e-05	0.00338	CbGpPWpGaD
Raloxifene—HTR6—GPCR ligand binding—CCR6—Crohn's disease	2.77e-05	0.00335	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	2.7e-05	0.00328	CbGpPWpGaD
Raloxifene—ESR1—Leptin signaling pathway—IL1B—Crohn's disease	2.68e-05	0.00325	CbGpPWpGaD
Raloxifene—ESR2—Gene Expression—DNMT3A—Crohn's disease	2.6e-05	0.00316	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—PTRF—Crohn's disease	2.58e-05	0.00313	CbGpPWpGaD
Raloxifene—EBP—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	2.54e-05	0.00307	CbGpPWpGaD
Raloxifene—HTR2B—GPCR ligand binding—CCR6—Crohn's disease	2.53e-05	0.00306	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	2.52e-05	0.00306	CbGpPWpGaD
Raloxifene—HTR6—GPCR ligand binding—PTGER4—Crohn's disease	2.44e-05	0.00295	CbGpPWpGaD
Raloxifene—CYP2C8—Arachidonic acid metabolism—PTGS2—Crohn's disease	2.42e-05	0.00293	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	2.36e-05	0.00287	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—CCR9—Crohn's disease	2.36e-05	0.00286	CbGpPWpGaD
Raloxifene—AOX1—Disease—GCKR—Crohn's disease	2.35e-05	0.00285	CbGpPWpGaD
Raloxifene—ESR2—Generic Transcription Pathway—SMAD3—Crohn's disease	2.29e-05	0.00278	CbGpPWpGaD
Raloxifene—ESR1—Leptin signaling pathway—STAT3—Crohn's disease	2.25e-05	0.00272	CbGpPWpGaD
Raloxifene—HTR2B—GPCR ligand binding—PTGER4—Crohn's disease	2.22e-05	0.0027	CbGpPWpGaD
Raloxifene—EBP—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.22e-05	0.00269	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—GPR65—Crohn's disease	2.19e-05	0.00266	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—FADS1—Crohn's disease	2.17e-05	0.00264	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—CCR9—Crohn's disease	2.15e-05	0.00261	CbGpPWpGaD
Raloxifene—ESR2—SIDS Susceptibility Pathways—TNF—Crohn's disease	2.15e-05	0.0026	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—CCR9—Crohn's disease	2.14e-05	0.0026	CbGpPWpGaD
Raloxifene—AOX1—Disease—SLC11A1—Crohn's disease	2.08e-05	0.00252	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	2.07e-05	0.00251	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—GPX4—Crohn's disease	2.04e-05	0.00247	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—GPR65—Crohn's disease	2e-05	0.00243	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—GPR65—Crohn's disease	1.99e-05	0.00242	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—GCKR—Crohn's disease	1.97e-05	0.00238	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—CCR9—Crohn's disease	1.96e-05	0.00237	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—ACKR2—Crohn's disease	1.93e-05	0.00234	CbGpPWpGaD
Raloxifene—ESR1—ATF-2 transcription factor network—IL6—Crohn's disease	1.9e-05	0.0023	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—MLN—Crohn's disease	1.83e-05	0.00222	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	1.82e-05	0.00221	CbGpPWpGaD
Raloxifene—ESR1—Signaling by ERBB4—TYK2—Crohn's disease	1.82e-05	0.00221	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—GPR65—Crohn's disease	1.82e-05	0.00221	CbGpPWpGaD
Raloxifene—AOX1—Disease—RBX1—Crohn's disease	1.78e-05	0.00216	CbGpPWpGaD
Raloxifene—AOX1—Disease—HSPA1B—Crohn's disease	1.78e-05	0.00216	CbGpPWpGaD
Raloxifene—CYP3A4—Metapathway biotransformation—GPX4—Crohn's disease	1.77e-05	0.00215	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	1.76e-05	0.00214	CbGpPWpGaD
Raloxifene—ESR2—Gene Expression—HSPA1B—Crohn's disease	1.76e-05	0.00213	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—ACKR2—Crohn's disease	1.76e-05	0.00213	CbGpPWpGaD
Raloxifene—ESR1—Signaling by ERBB4—JAK2—Crohn's disease	1.74e-05	0.00211	CbGpPWpGaD
Raloxifene—ESR2—SIDS Susceptibility Pathways—IL6—Crohn's disease	1.73e-05	0.0021	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—PLA2G4F—Crohn's disease	1.7e-05	0.00206	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—TAGAP—Crohn's disease	1.67e-05	0.00203	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—MLN—Crohn's disease	1.67e-05	0.00202	CbGpPWpGaD
Raloxifene—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	1.66e-05	0.00201	CbGpPWpGaD
Raloxifene—ESR1—AP-1 transcription factor network—IL6—Crohn's disease	1.66e-05	0.00201	CbGpPWpGaD
Raloxifene—ESR1—Generic Transcription Pathway—UBE2D1—Crohn's disease	1.62e-05	0.00196	CbGpPWpGaD
Raloxifene—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	1.58e-05	0.00192	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—CCR6—Crohn's disease	1.56e-05	0.0019	CbGpPWpGaD
Raloxifene—AOX1—Disease—UBE2D1—Crohn's disease	1.56e-05	0.00189	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—ZFP36L1—Crohn's disease	1.54e-05	0.00187	CbGpPWpGaD
Raloxifene—ESR2—Gene Expression—UBE2D1—Crohn's disease	1.54e-05	0.00187	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—TAGAP—Crohn's disease	1.53e-05	0.00185	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—ACKR2—Crohn's disease	1.47e-05	0.00178	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—RSPO3—Crohn's disease	1.46e-05	0.00177	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—MTMR3—Crohn's disease	1.44e-05	0.00175	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—CCR6—Crohn's disease	1.43e-05	0.00173	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—CCR6—Crohn's disease	1.42e-05	0.00172	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—MLN—Crohn's disease	1.39e-05	0.00168	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—SEL1L—Crohn's disease	1.38e-05	0.00168	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—PTGER4—Crohn's disease	1.38e-05	0.00167	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	1.37e-05	0.00166	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	1.36e-05	0.00165	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—RSPO3—Crohn's disease	1.33e-05	0.00162	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—DNMT3A—Crohn's disease	1.31e-05	0.00159	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—CCR6—Crohn's disease	1.3e-05	0.00157	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	1.29e-05	0.00156	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—TAGAP—Crohn's disease	1.27e-05	0.00154	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CCR9—Crohn's disease	1.27e-05	0.00154	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—SEL1L—Crohn's disease	1.26e-05	0.00153	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—PTGER4—Crohn's disease	1.26e-05	0.00152	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—PTGER4—Crohn's disease	1.25e-05	0.00152	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—GPR65—Crohn's disease	1.18e-05	0.00143	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—IL3—Crohn's disease	1.17e-05	0.00142	CbGpPWpGaD
Raloxifene—HTR6—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	1.17e-05	0.00142	CbGpPWpGaD
Raloxifene—ESR1—Generic Transcription Pathway—SMAD3—Crohn's disease	1.16e-05	0.0014	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CCR9—Crohn's disease	1.16e-05	0.0014	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—PTGER4—Crohn's disease	1.14e-05	0.00138	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—RASGRP1—Crohn's disease	1.13e-05	0.00138	CbGpPWpGaD
Raloxifene—EBP—Metabolism—ALB—Crohn's disease	1.13e-05	0.00137	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—FADS1—Crohn's disease	1.12e-05	0.00136	CbGpPWpGaD
Raloxifene—AOX1—Disease—SMAD3—Crohn's disease	1.12e-05	0.00135	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—RSPO3—Crohn's disease	1.11e-05	0.00135	CbGpPWpGaD
Raloxifene—ESR2—Gene Expression—SMAD3—Crohn's disease	1.1e-05	0.00134	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—PLA2G4F—Crohn's disease	1.09e-05	0.00132	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—GPR65—Crohn's disease	1.07e-05	0.0013	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—IL3—Crohn's disease	1.07e-05	0.0013	CbGpPWpGaD
Raloxifene—HTR2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	1.07e-05	0.0013	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—IL3—Crohn's disease	1.06e-05	0.00129	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—GPX4—Crohn's disease	1.05e-05	0.00128	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—SEL1L—Crohn's disease	1.05e-05	0.00128	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—RASGRP1—Crohn's disease	1.04e-05	0.00126	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—RASGRP1—Crohn's disease	1.03e-05	0.00125	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—GCKR—Crohn's disease	1.02e-05	0.00123	CbGpPWpGaD
Raloxifene—EBP—Metabolism—PTGS2—Crohn's disease	9.88e-06	0.0012	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—IL3—Crohn's disease	9.72e-06	0.00118	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CCR9—Crohn's disease	9.63e-06	0.00117	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—RASGRP1—Crohn's disease	9.4e-06	0.00114	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—MTMR3—Crohn's disease	9.27e-06	0.00112	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PLA2G4F—Crohn's disease	9.23e-06	0.00112	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	9.2e-06	0.00112	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—GPR65—Crohn's disease	8.95e-06	0.00109	CbGpPWpGaD
Raloxifene—HTR6—GPCR ligand binding—CXCL8—Crohn's disease	8.92e-06	0.00108	CbGpPWpGaD
Raloxifene—ESR1—Signaling by ERBB4—IL6—Crohn's disease	8.91e-06	0.00108	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—HSPA1B—Crohn's disease	8.87e-06	0.00108	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CCR6—Crohn's disease	8.39e-06	0.00102	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—IL2RA—Crohn's disease	8.21e-06	0.000996	CbGpPWpGaD
Raloxifene—HTR2B—GPCR ligand binding—CXCL8—Crohn's disease	8.14e-06	0.000987	CbGpPWpGaD
Raloxifene—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	8.11e-06	0.000983	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—MTMR3—Crohn's disease	7.85e-06	0.000951	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—UBE2D1—Crohn's disease	7.78e-06	0.000943	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CCR6—Crohn's disease	7.66e-06	0.000928	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—RBX1—Crohn's disease	7.59e-06	0.00092	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—IL2RA—Crohn's disease	7.5e-06	0.000909	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—IL2RA—Crohn's disease	7.46e-06	0.000904	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—PTGER4—Crohn's disease	7.39e-06	0.000895	CbGpPWpGaD
Raloxifene—AOX1—Disease—TYK2—Crohn's disease	7.28e-06	0.000883	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	7.27e-06	0.000881	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—FADS1—Crohn's disease	7.22e-06	0.000875	CbGpPWpGaD
Raloxifene—AOX1—Disease—JAK2—Crohn's disease	6.95e-06	0.000842	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—RBX1—Crohn's disease	6.92e-06	0.00084	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—IL2RA—Crohn's disease	6.81e-06	0.000826	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—GPX4—Crohn's disease	6.76e-06	0.00082	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—PTGER4—Crohn's disease	6.74e-06	0.000817	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—UBE2D1—Crohn's disease	6.65e-06	0.000807	CbGpPWpGaD
Raloxifene—AOX1—Disease—CD4—Crohn's disease	6.59e-06	0.000798	CbGpPWpGaD
Raloxifene—AOX1—Disease—PTGS2—Crohn's disease	6.54e-06	0.000793	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—GCKR—Crohn's disease	6.53e-06	0.000792	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—RIPK2—Crohn's disease	6.45e-06	0.000782	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CCR6—Crohn's disease	6.38e-06	0.000773	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	6.36e-06	0.000771	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—IL3—Crohn's disease	6.29e-06	0.000763	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—ALB—Crohn's disease	6.26e-06	0.000759	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—FADS1—Crohn's disease	6.11e-06	0.000741	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—RASGRP1—Crohn's disease	6.08e-06	0.000738	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—UBE2D1—Crohn's disease	6.07e-06	0.000736	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—RIPK2—Crohn's disease	5.89e-06	0.000714	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—RBX1—Crohn's disease	5.77e-06	0.000699	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—IL3—Crohn's disease	5.74e-06	0.000696	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—GPX4—Crohn's disease	5.72e-06	0.000694	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—PTGER4—Crohn's disease	5.62e-06	0.000681	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—SMAD3—Crohn's disease	5.57e-06	0.000675	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—RASGRP1—Crohn's disease	5.55e-06	0.000673	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—GCKR—Crohn's disease	5.53e-06	0.00067	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—JAK2—Crohn's disease	5.52e-06	0.000669	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—SOCS1—Crohn's disease	5.51e-06	0.000668	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—PTGS2—Crohn's disease	5.47e-06	0.000664	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—TYK2—Crohn's disease	5.26e-06	0.000637	CbGpPWpGaD
Raloxifene—AOX1—Disease—STAT3—Crohn's disease	5.1e-06	0.000618	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—UBE2D1—Crohn's disease	5.06e-06	0.000613	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—JAK2—Crohn's disease	5.04e-06	0.000611	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—CXCL8—Crohn's disease	5.04e-06	0.000611	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—SOCS1—Crohn's disease	5.03e-06	0.00061	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—JAK2—Crohn's disease	5.01e-06	0.000608	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	4.95e-06	0.000601	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—RIPK2—Crohn's disease	4.9e-06	0.000595	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—TYK2—Crohn's disease	4.8e-06	0.000582	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—IL3—Crohn's disease	4.78e-06	0.00058	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—SMAD3—Crohn's disease	4.76e-06	0.000577	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—RASGRP1—Crohn's disease	4.63e-06	0.000561	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—CXCL8—Crohn's disease	4.6e-06	0.000558	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—JAK2—Crohn's disease	4.58e-06	0.000555	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—CXCL8—Crohn's disease	4.58e-06	0.000555	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—IL2RA—Crohn's disease	4.41e-06	0.000534	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—SMAD3—Crohn's disease	4.34e-06	0.000527	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—MTMR3—Crohn's disease	4.21e-06	0.000511	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—SOCS1—Crohn's disease	4.19e-06	0.000508	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—CXCL8—Crohn's disease	4.18e-06	0.000506	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—IL2RA—Crohn's disease	4.02e-06	0.000488	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	3.95e-06	0.000479	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—SMAD3—Crohn's disease	3.62e-06	0.000439	CbGpPWpGaD
Raloxifene—AOX1—Disease—IL6—Crohn's disease	3.56e-06	0.000432	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	3.46e-06	0.000419	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—IL2RA—Crohn's disease	3.35e-06	0.000406	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—FADS1—Crohn's disease	3.28e-06	0.000398	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—ALB—Crohn's disease	3.24e-06	0.000392	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—TYK2—Crohn's disease	3.1e-06	0.000376	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GPX4—Crohn's disease	3.07e-06	0.000372	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GCKR—Crohn's disease	2.97e-06	0.00036	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—JAK2—Crohn's disease	2.96e-06	0.000359	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—TYK2—Crohn's disease	2.83e-06	0.000344	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—PTGS2—Crohn's disease	2.83e-06	0.000343	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—JAK2—Crohn's disease	2.7e-06	0.000328	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CXCL8—Crohn's disease	2.7e-06	0.000328	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—IL6—Crohn's disease	2.57e-06	0.000312	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CXCL8—Crohn's disease	2.47e-06	0.000299	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—TYK2—Crohn's disease	2.36e-06	0.000286	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—IL6—Crohn's disease	2.35e-06	0.000284	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—JAK2—Crohn's disease	2.25e-06	0.000273	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—STAT3—Crohn's disease	2.17e-06	0.000264	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—ALB—Crohn's disease	2.08e-06	0.000252	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CXCL8—Crohn's disease	2.06e-06	0.000249	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—STAT3—Crohn's disease	1.98e-06	0.000241	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—PTGS2—Crohn's disease	1.82e-06	0.00022	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—ALB—Crohn's disease	1.76e-06	0.000213	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—STAT3—Crohn's disease	1.65e-06	0.0002	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PTGS2—Crohn's disease	1.54e-06	0.000187	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—IL6—Crohn's disease	1.52e-06	0.000184	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—IL6—Crohn's disease	1.39e-06	0.000168	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—IL6—Crohn's disease	1.15e-06	0.00014	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—ALB—Crohn's disease	9.44e-07	0.000114	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PTGS2—Crohn's disease	8.26e-07	0.0001	CbGpPWpGaD
